We compared ctDNA analysis and tDNA analysis for the detection of the EGFR mutation required for the targeted therapy of NSCLC, and the sensitivity of ctDNA analysis was 57.3%, which was slightly lower than that reported in previous studies [18,19,23,25]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.